LLY Stock - Eli Lilly And Co

LLY Stock Chart

LLY Profile

Eli Lilly and Company operates as a global pharmaceutical leader, specializing in the discovery, development, and distribution of human pharmaceuticals. Established in 1876 and headquartered in Indianapolis, Indiana, the company offers a comprehensive range of medications worldwide. Key products include treatments for diabetes such as Basaglar, Humalog, and Jardiance, alongside innovative therapies like Alimta for non-small cell lung cancer and Cyramza for various cancers including gastric, colorectal, and lung cancers.

The company also provides solutions for autoimmune diseases and inflammatory conditions through medications like Taltz for plaque psoriasis and rheumatoid arthritis, and Emgality for migraine prevention. Additionally, Eli Lilly's portfolio encompasses treatments for mental health disorders such as Cymbalta for depression and anxiety, and antipsychotic medications like Zyprexa for schizophrenia and bipolar disorders.

Eli Lilly is actively involved in addvancing COVID-19 therapies with Bamlanivimab and etesevimab, along with Bebtelovimab. The company collaborates with leading biotech firms including Incyte Corporation, Boehringer Ingelheim Pharmaceuticals, and AbCellera Biologics to expand its research and development efforts. This collaborative approach underscores Eli Lilly's commitment to innovation and improving healthcare outcomes globally.

LLY Revenue Chart

LLY Earnings

Analyst Ratings